Moreover, β-cell dysfunction is apparently progressive and as noted in UKPDS, there is a simultaneous worsening of insulin resistance that is caused by weight gain during the course of the disorder.[1] Therefore, insulin therapy is likely to be required in almost all subjects with type 2 DM if they survive long enough, because oral agents will then be unable to maintain desirable glycemic control. This evidence concerns the gene INS and Insulin resistance.